Meanwhile, PPP2R2B overexpression dramatically enhanced the efficacy of cisplatin in vivo, evidenced by a more prominent reduction in tumor volume and weight than that observed in the empty vector plus cisplatin group (Fig. 3A-F). This evidence concerns the gene PPP2R2B and neoplasm.